Home › Trial NCT04305470
Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma
- Trial IDNCT04305470
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorNX Development Corp
- Enrollment108
- Start date2020-10-28
- ConditionsMeningioma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.